← Product Code [OMP](/submissions/SU/subpart-e%E2%80%94surgical-devices/OMP) · K102001 # MODIFICATION TO RENASYS EZ PLUS NEGATIVE PRESSURE WOUND THERAPY (K102001) _Smith & Nephew, Inc. · OMP · Aug 6, 2010 · General, Plastic Surgery · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/OMP/K102001 ## Device Facts - **Applicant:** Smith & Nephew, Inc. - **Product Code:** [OMP](/submissions/SU/subpart-e%E2%80%94surgical-devices/OMP.md) - **Decision Date:** Aug 6, 2010 - **Decision:** SESE - **Submission Type:** Special - **Regulation:** 21 CFR 878.4780 - **Device Class:** Class 2 - **Review Panel:** General, Plastic Surgery - **Attributes:** Therapeutic ## Intended Use The RENASYS EZ PLUS is indicated for patients who would benefit from a suction device (negative pressure wound therapy) as it may promote wound healing via removal of fluids, including irrigation and body fluids, wound exudates and infectious materials. Examples of appropriate wound types include: - Chronic - Acute - Traumatic - Sub-acute and dehisced wounds - Ulcers (such as pressure or diabetic) - Partial-thickness burns - Flaps and grafts ## Device Story Renasys EZ PLUS is a lightweight, powered suction pump for negative pressure wound therapy (NPWT). Device connects to wound dressing via tube and disposable canister; applies continual or intermittent negative pressure to remove wound exudates, irrigation fluids, and infectious materials. Operates via mains power or internal battery. Used in hospital or homecare settings. Healthcare providers monitor wound status and device output to manage wound healing. Benefits include promotion of wound healing through effective fluid management. ## Clinical Evidence Bench testing only. Electrical safety and electromagnetic compatibility testing performed per UL 60601-1, IEC 60601-1, and IEC 60601-1-2. Performance testing verified design specifications and substantial equivalence to predicate. ## Technological Characteristics Powered suction pump; mains or internal battery operated. Compatible with existing Smith & Nephew wound dressing kits. Electrical safety per UL 60601-1/IEC 60601-1; EMC per IEC 60601-1-2. ## Regulatory Identification A powered suction pump is a portable, AC-powered or compressed air-powered device intended to be used to remove infectious materials from wounds or fluids from a patient's airway or respiratory support system. The device may be used during surgery in the operating room or at the patient's bedside. The device may include a microbial filter. ## Predicate Devices - Renasys™ EZ ([K091470](/device/K091470.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ #### 510(k) Summary #### General Information Submitters Name/Address: Smith & Nephew, Inc 970 Lake Carillon Drive Suite 110 St. Petersburg, FL 33716 AUG 2010 - 6 Establishment Registration Number: Contact Person: Phone Number: Date Prepared: Device Description Trade Name: Generic/Common Name: Classification Name: Predicate Device Information Smith & Nephew, Inc 970 Lake Carillon Drive Suite 110 St. Petersburg, FL 33716 3006760724 Laura Reynolds Regulatory Affairs Manager (727) 329-7702 August 4, 2010 Renasys™ EZ PLUS Negative Pressure Wound Therapy Powered Suction Pump Powered Suction Pump; 21 CFR 878.4780 Product Code: OMP | 510(k) # | Device | Clearance Date | |----------|-------------|----------------| | K091470 | Renasys™ EZ | 07/09/2009 | #### Device Description The Renasys EZ PLUS NPWT device is a lightweight, suction device intended for wound management via application of continual or intermittent negative pressure wound therapy to the wound for removal of fluids, including wound exudates, irrigation fluids, and infectious materials. The pump is connected to the wound dressing via a tube connected to a disposable canister. The device provides negative pressure wound therapy to the wound at a range of pressure settings and removes exudates from the wound site to the disposable canister. The device can operate either by a mains power supply or internal battery. Renasys EZ PLUS is suitable for use in either a hospital or homecare setting. Renasvs EZ PLUS is compatible with existing Smith & Nephew wound dressing kits currently on the market. {1}------------------------------------------------ #### Indications for Use The RENASYS EZ PLUS is indicated for patients who would benefit from a suction device (negative pressure wound therapy) as it may promote wound healing via removal of fluids, including irrigation and body fluids, wound exudates and infectious materials. Examples of appropriate wound types include: - Chronic . - Acute . - . Traumatic - . Sub-acute and dehisced wounds - Ulcers (such as pressure or diabetic) . - Partial-thickness burns . - Flaps and grafts . ## Non-Clinical Tests (Bench) Testing in accordance with UL 60601-1 and IEC 60601-1 was conducted for electrical safety. Testing in accordance with IEC 60601-1-2 was conducted for electromagnetic compatibility. Testing was conducted to verify the changes in the Renasys EZ PLUS met design specifications and demonstrated substantial equivalence to its predicate device. ## Summary of Safety and Effectiveness In establishing substantial equivalence to the current marketed devices, Smith & Nephew, Inc evaluated the indications for use, materials, technology, product specifications and energy requirements of the device. Performance testing and electrical safety testing has been successfully completed to demonstrate that the Renasys EZ PLUS is substantially equivalent to the marketed device and is safe and effective for the intended use. {2}------------------------------------------------ # DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized eagle or bird-like figure with outstretched wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the bird-like figure. AUG - 0 2010 Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002 Smith & Nephew, Inc. % Ms. Laura Revnolds Regulatory Affairs Manager 970 Lake Carillon Drive, Suite 110 St. Petersburg, Florida 33716 Re: K102001 Trade/Device Name: Renasys™ EZ PLUS Negative Pressure Wound Therapy Regulation Number: 21 CFR 878.4780 Regulation Name: Powered suction pump Regulatory Class: Class II Product Code: OMP Dated: July 12, 2010 Received: July 15, 2010 Dear Ms. Reynolds: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act {3}------------------------------------------------ Page 2 - Ms. Laura Reynolds or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Sincerely yours, Mark N. Melkerson Director Division of Surgical, Orthopedic And Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ #### Indications for Use 510(k) Number (if known): K102001 AUG - 6 2010 Device Name: Renasys™ EZ Plus Indications for Use: The RENASYS EZ PLUS is indicated for patients who would benefit from a suction device (negative pressure wound therapy) as it may promote wound healing via removal of fluids, including irrigation and body fluids, wound exudates and infectious materials. Examples of appropriate wound types include: - Chronic ◆ - Acute . - Traumatic . - Sub-acute and dehisced wounds . - Ulcers (such as pressure or diabetic) ● - Partial-thickness burns ● - Flaps and grafts . Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) currence of CDRH, Office of Device Evaluation (ODE) (Division Sign-Off) Division of Surgical, Orthopedic, and Restorative Devices 510(k) Number K102001 --- **Source:** [https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/OMP/K102001](https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/OMP/K102001) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com